Sensitizing human cervical cancer cells in vitro to ionizing radiation with interferon β or γ

Gamma interferon; Female genital diseases; Uterine diseases; Dose activity relation; Clonogenic assay; Mechanism of action; TP53 Gene; In vitro; Tumor cell; Uterus; Malignant tumor; Radiosensitivity; Beta interferon; Interféron gamma; Appareil génital femelle pathologie; Utérus pathologie; Relation dose réponse; Test clonogénicité; Mécanisme action; Gène TP53; Cellule tumorale; Utérus; Tumeur maligne; Radiosensibilité; Interféron bêta

Disciplines :

Oncology

Author, co-author :

Grueninger, L

Cottin, Y-X

Li, Y-X

Noël, Agnès ; Université de Liège - ULiège

Ozsahin, M

COUCKE, Philippe ; Centre Hospitalier Universitaire Vaudois

Language :

English

Title :

Sensitizing human cervical cancer cells in vitro to ionizing radiation with interferon β or γ

Publication date :

1999

Journal title :

Radiation Research

ISSN :

0033-7587

Publisher :

Kluge Carden Jennnings Pub Co, Charlottesville, United States - Virginia

Volume :

152

Issue :

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 18 February 2010

Statistics

Number of views

80 (10 by ULiège)

Number of downloads

217 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

H. Zur Hausen, Papillomaviruses in human cancer. Appl. Pathol. 5, 19-24 (1987).
K. Munger, M. Scheffner, J. M. Huibregtse and P. M. Howley, Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Cancer Surv. 12, 197-217 (1992).
N. Dyson, P. M. Howley, K. Münger and E. Harlow, The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934-937 (1989).
B. A. Werness, A. J. Levine and P. M. Howley, Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79 (1990).
D. P. Lane, p53, guardian of the genome. Nature 358, 15-16 (1992).
D. Ron, Inducible growth arrest: New mechanistic insights. Proc. Natl. Acad. Sci. USA 91, 1985-1986 (1994)
J. A. Pietenpol, T. Tokino, S. Thiagalingam, W. S. El-Deiry, K. W. Kinzler and B. Vogelstein, Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA 91, 1998-2002 (1994).
M. B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein and R. W. Craig, Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
S. W. Lowe, H. E. Ruley, T. Jacks and D. E. Housman, p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967 (1993).
T. D. Kessis, R. J. Slebos, W. G. Nelson, M. B. Kastan, B. S. Plunkett, S. M. Han, A. T. Lorincz, L. Hedrick and K. R. Cho, Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 90, 3988-3992 (1993).
S. W. Lowe, S. Bodis, A. McClatchey, L. Remington, H. E. Ruley, D. E. Fisher and D. E. Housman and T. Jacks, p53 status and efficacy of cancer therapy in vivo. Science 266, 807-810 (1994).
D. S. Kapp and A. J. Giaccia, New directions for radiation biology research in cancer of the uterine cervix. Natl. Cancer Inst. Monogr. 21, 131-139 (1996).
F. de Marco and M. L. Marcante, HPV-16 E6-E7 differential transcription induced in SiHa cervical cancer cell line by interferons. J. Biol. Regul. Homeost. Agents 7, 15-21 (1993).
P. Chomczynski and N. Sacchi, Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
A. Isaacs and J. Lindenmann, Virus interference I. The interferon. Proc. R. Soc. Biol. 147, 258-263 (1987).
F. Dorner, M. Scriba and R. Weil, Interferon: Evidence for its glycoprotein nature. Proc. Natl. Acad. Sci. USA 70, 1981-1985 (1973).
J. N. M. Ijzermans and R. L. Marquet, Interferon-gamma: A review. Immunobiology 179, 456-473 (1989).
S. Pellegrini and C. Schindler, Early events in signalling by interferons. Trends Biochem. Sci. 18, 338-342 (1993).
E. De Maeyer and J. De Maeyer-Guignard, Interferon γ. Curr. Opin. Immunol. 4, 321-326 (1992).
E. Samuel, Antiviral actions of interferon: Interferon-regulated cellular proteins on their surprisingly selective antiviral activities. Virology 1, 183 (1991).
Z. Reiter, Interferon - a major regulator of natural killer cell-mediated cytotoxicity. J. Interferon Res. 13, 247 (1993).
M. Namba, S. Yamamoto, H. Tanaka, T. Kanamori, M. Nobuhara and T. Kimoto, In vitro and in vivo studies on potentiation of cytotoxic effects of anticancer drugs or cobalt 60 gamma rays by interferon on human neoplastic cells. Cancer 54, 2262-2267 (1984).
T. Nederman and G. Benediktsson, Effects of interferon on growth rate and radiation sensitivity of cultured human glioma cells. Acta Radiol. Oncol. 21, 231-234 (1982).
D. Kardamakis, N. E. Gillies, R. L. Souhami and P. C. L. Bewerley, Recombinant human interferon alpha-2b enhances the radiosensitivity of small cell lung cancer in vitro. Anticancer Res. 9, 1041-1044 (1989).
P. Maasilta, L. R. Holsti, M. Halme, L. Kivisaari, K. Cantell and K. Mattson, Natural alpha-interferon in combination with hyperfractionated radiotherapy in the treatment of non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 23, 863-868 (1992).
J. Torrisi, C. Berg, E. Bonnem and A. Dritschilo, The combined use of interferon and radiotherapy in cancer management. Semin. Oncol. 13, 78-83 (1986).
R. Angioli, B. U. Sevin, J. P. Perras, M. Untch, R. D. Hightower, H. N. Nguyen, A. Steren, C. Villani and H. E. Averette, Rationale of combining radiation and interferon for the treatment of cervical cancer. Oncology 49, 445-449 (1992).
J. M. Huibregtse, M. Scheffner and P. M. Howley, Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell Biol. 13, 775-784 (1993).
C. Swan, S. D. Vernon and J. P. Icenogle, Cellular proteins involved in papillomavirus-induced transformation. Arch. Virol. 138, 105-115 (1994).
C. Agarwal, J. R. Hembree, E. A. Rorke and R. L. Eckert, Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes. Cancer Res. 54, 2108-2112 (1994).
C. D. Woodworth, U. Lichti, S. Simpson, C. H. Evans and J. A. DiPaolo, Leukoregulin and γ-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells. Cancer Res. 52, 456-463 (1992).
A. Nawa, Y. Nishiyama, N. Yamamoto, K. Maeno, S. Goto and Y. Tomoda, Selective suppression of human papilloma virus type 18 mRNA level in HeLa cells by interferon. Biochem. Biophys. Res. Commun. 170, 793-799 (1990).
A. Dritschilo, K. Mossman, M. Gray and T. Sreevalsan, Potentiation of radiation injury by interferon. Am. J. Clin. Oncol. 5, 79-82 (1982).
M. N. Gould, R. C. Kakria, S. Olson and E. C. Borden, Radiosensitization of human bronchogenic carcinoma cells by interferon beta. J. Interferon Res. 4, 123-128 (1984).
J. F. R. Kerr, C. M. Winterford and B. V. Harmon, Apoptosis: Its significance in cancer and cancer therapy. Cancer 73, 2013-2026 (1994).
N. K. Ossina, A. Cannas, V. C. Powers, P. A. Fitzpatrick, J. D. Knight, J. R. Gilbert, E. M. Shekhtman, L. D. Tomei, S. R. Umansky and M. C. Kiefer, Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J. Biol. Chem. 272, 16351-16357 (1997).
I. Arany, C. M. Fleischmann, S. K. Tyring and W. R. Fleischmann, Interferon regulates expression of mda-6/WAF1/CIP1 and cyclin-dependent kinases independently from p53 in B16 murine melanoma cells. Biochem. Biophys. Res. Commun. 233, 678-680 (1997).